Insider · CIK 0001244110
Paul J Lytle
Files at ACTU (ACTUATE THERAPEUTICS, INC.). First filing -, latest -.
In brief
Paul J Lytle files SEC Form 4 as CFO at ACTU (ACTUATE THERAPEUTICS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Paul J Lytle has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | ACTU ACTUATE THERAPEUTICS, INC. | AGrant or award Employee Stock Option (right to buy)derivative | +105,000 | $0.00 | $0 | 105,000 | Apr 1, 2026 |
| Apr 1, 2025 | ACTU ACTUATE THERAPEUTICS, INC. | AGrant or award Employee Stock Option (right to buy)derivative | +49,394 | $0.00 | $0 | 49,394 | Apr 2, 2025 |
| Apr 1, 2025 | ACTU ACTUATE THERAPEUTICS, INC. | AGrant or award Employee Stock Option (right to buy)derivative | +41,899 | $0.00 | $0 | 41,899 | Apr 2, 2025 |
Questions about Paul J Lytle
Answered from the filings on this page, as of the latest one.
Is Paul J Lytle buying or selling?
Paul J Lytle has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Paul J Lytle's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Paul J Lytle has 0.
Where does Paul J Lytle file Form 4?
Paul J Lytle has filed Form 4 at ACTU (ACTUATE THERAPEUTICS, INC.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.